Litcius/Paper detail

Cardamonin targets KEAP1/NRF2 signaling for protection against atherosclerosis

Pengfei Fan, Huali Meng, Wenhao Hao, Zheng Yan, Hui Li, Zhiyue Zhang, Lei Du, Xin Guo, Dongliang Wang, Yunyan Wang, Hao Wu

2023Food & Function20 citationsDOI

Abstract

gene. Surprisingly, AHR was not required for CAD's action on the activation of NRF2/HO1 signaling since AHR gene silencing did not reverse this effect. Furthermore, a molecular docking assay showed a strong binding potential of CAD to the Kelch domain of the Kelch-like ECH-associated protein 1 (KEAP1) which sequesters NRF2 in the cytoplasm. Both CAD and the Kelch domain inhibitor Ki696 promoted NRF2 nuclear translocation, whereas the combination of CAD and Ki696 did not yield a greater effect compared with either CAD or Ki696, confirming the interaction of CAD with the Kelch domain. This work provides an experimental basis for CAD as a novel and effective bioactive food component in future AS interventions.

Topics & Concepts

Tumor necrosis factor alphaInflammationOxidative stressTranscription factorKEAP1Aryl hydrocarbon receptorCancer researchBiologyCell biologyChemistryImmunologyEndocrinologyBiochemistryGeneGenomics, phytochemicals, and oxidative stressGinger and Zingiberaceae researchCholesterol and Lipid Metabolism
Cardamonin targets KEAP1/NRF2 signaling for protection against atherosclerosis | Litcius